Search Results Search Sort by RelevanceMost Recent Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673. Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697. Viewpoint Oct 2021 Whoever Does Image-Guided Palliative Care Needs to Be Properly Trained to Do So Jay A. Requarth, MD Some clinicians offering image-guided procedures have little training in palliative medicine, which is both a clinical and an ethical problem. AMA J Ethics. 2021;23(10):E826-831. doi: 10.1001/amajethics.2021.826. Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936. Policy Forum Nov 2019 Why Quality-of-Life Data Collection and Use Should Be Standardized When Evaluating Candidates for Hand Transplantation Martin Kumnig, PhD, MSc, Emma K. Massey, PhD, and Lisa S. Parker, PhD Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness. AMA J Ethics. 2019;21(11):E974-979. doi: 10.1001/amajethics.2019.974. Medicine and Society Jul 2021 When Disability Is Defined by Behavior, Outcome Measures Should Not Promote “Passing” Ari Ne’eman Defining typical appearance as a goal of health service provision is harmful and unnecessary for traits that are stigmatized but neither harmful nor distressing. AMA J Ethics. 2021;23(7):E569-575. doi: 10.1001/amajethics.2021.569. State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705. Case and Commentary Aug 2023 Should Organizational Investment in Robotic Surgical Technology Ever Influence Surgeons’ Decisions About Surgical Approach to Patients’ Surgical Care? Ryan D. Rosen, DO and David A. Edelman, MD, MSHPEd Costs partly determine organizational robotics, but questions remain about whether and to what extent they should influence care decisions. AMA J Ethics. 2023;25(8):E575-582. doi: 10.1001/amajethics.2023.575. Case and Commentary Aug 2023 How Should Risk Be Communicated to Patients When Developing Resident Surgeon Robotic Skills? Matthew C. Bobel, MD and Robert K. Cleary, MD This article suggests strategies for how to disclose the nature and scope of resident surgeon involvement in managing intraoperative care. AMA J Ethics. 2023;25(8):E583-588. doi: 10.1001/amajethics.2023.583. Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Next page Next › Last page Last »
Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673.
Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697.
Viewpoint Oct 2021 Whoever Does Image-Guided Palliative Care Needs to Be Properly Trained to Do So Jay A. Requarth, MD Some clinicians offering image-guided procedures have little training in palliative medicine, which is both a clinical and an ethical problem. AMA J Ethics. 2021;23(10):E826-831. doi: 10.1001/amajethics.2021.826.
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
Policy Forum Nov 2019 Why Quality-of-Life Data Collection and Use Should Be Standardized When Evaluating Candidates for Hand Transplantation Martin Kumnig, PhD, MSc, Emma K. Massey, PhD, and Lisa S. Parker, PhD Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness. AMA J Ethics. 2019;21(11):E974-979. doi: 10.1001/amajethics.2019.974.
Medicine and Society Jul 2021 When Disability Is Defined by Behavior, Outcome Measures Should Not Promote “Passing” Ari Ne’eman Defining typical appearance as a goal of health service provision is harmful and unnecessary for traits that are stigmatized but neither harmful nor distressing. AMA J Ethics. 2021;23(7):E569-575. doi: 10.1001/amajethics.2021.569.
State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705.
Case and Commentary Aug 2023 Should Organizational Investment in Robotic Surgical Technology Ever Influence Surgeons’ Decisions About Surgical Approach to Patients’ Surgical Care? Ryan D. Rosen, DO and David A. Edelman, MD, MSHPEd Costs partly determine organizational robotics, but questions remain about whether and to what extent they should influence care decisions. AMA J Ethics. 2023;25(8):E575-582. doi: 10.1001/amajethics.2023.575.
Case and Commentary Aug 2023 How Should Risk Be Communicated to Patients When Developing Resident Surgeon Robotic Skills? Matthew C. Bobel, MD and Robert K. Cleary, MD This article suggests strategies for how to disclose the nature and scope of resident surgeon involvement in managing intraoperative care. AMA J Ethics. 2023;25(8):E583-588. doi: 10.1001/amajethics.2023.583.
Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063.
